Most authorship disagreements never become misconduct cases. A dispute over byline order, or a disagreement about whether someone’s contribution was substantial enough to warrant authorship, is normally something the author group works out directly, with the journal or institution acting as a referral point rather than an investigator (see CASRAI’s guide on resolving authorship order disputes). But some authorship conflicts do cross into formal research misconduct territory — triggering an institutional research integrity office inquiry rather than editorial mediation. This guide covers the actual definitional line: what separates a resolvable authorship dispute from an allegation that has to be handled under a misconduct policy, and what changes procedurally once that line is crossed.
The federal definition is narrower than most people assume
In the United States, the operative regulation is 42 CFR Part 93, administered by the Office of Research Integrity (ORI) for research supported by the Public Health Service (including NIH). It restricts “research misconduct” to three specific acts — fabrication, falsification, and plagiarism (FFP) — defined at 42 CFR 93.211, 93.212, and 93.227 respectively. Critically, the regulation’s own findings standard (42 CFR 93.103) requires all three of the following before a finding of misconduct can be made: (1) a significant departure from accepted practices of the relevant research community, (2) committed intentionally, knowingly, or recklessly, and (3) proven by a preponderance of the evidence. The regulation explicitly excludes honest error and honest differences of opinion from the definition of misconduct.
That exclusion matters directly for authorship disputes. A disagreement about who deserves to be listed as an author, or in what order, is — on its own — a difference of opinion about credit, not an act of fabrication, falsification, or plagiarism. That is why CASRAI’s own research misconduct dictionary entry is explicit that the US federal definition does not automatically reach authorship credit disputes, and why ICMJE and COPE both direct ordinary authorship-order disagreements to the author group and the institution for mediation, not to a misconduct inquiry (see the CASRAI guide above for that process in detail).
What actually crosses the line
An authorship dispute stops being a resolvable disagreement and becomes a misconduct allegation when it involves conduct that independently meets the FFP definition — the underlying act, not the fact that authorship is what’s being argued about, is what triggers the process. In practice, that includes:
Fabricating or falsifying the contribution record
If someone invents a contribution they didn’t make — falsifies lab notebook entries, backdates records, or fabricates data to manufacture a claim to authorship — that is fabrication or falsification under 42 CFR 93.211/93.212 regardless of what it’s in service of. The same applies in reverse: falsifying or destroying records to erase a legitimate contributor’s documented role. The dispute isn’t really about authorship at that point; authorship is the context in which an independent FFP violation occurred.
Ghost, guest, and gift authorship
This is the area where the answer genuinely depends on which framework applies. Under the narrow US federal (42 CFR Part 93) definition, ghost, guest, and gift authorship are not themselves FFP and so don’t automatically trigger an ORI-style misconduct finding — but they are still treated as serious integrity violations by journals, publishers, and most institutions, typically handled through COPE’s own procedural guidance (see CASRAI’s guide to COPE’s flowchart for suspected ghost, guest, or gift authorship) rather than a federal FFP inquiry. Other frameworks draw the line differently and more broadly: bodies such as the UK Research Integrity Office (UKRIO) and ALLEA’s European Code of Conduct for Research Integrity explicitly include ghost authorship, undisclosed conflicts of interest, and gross negligence within their own definitions of research misconduct, alongside FFP. An institution operating under one of those broader codes — or one that has simply written its own local misconduct policy to reach further than the federal minimum, which many US institutions do — can open a formal misconduct case over ghost or guest authorship even though ORI’s own jurisdiction would not reach it as FFP.
Misrepresenting expertise or role to secure authorship
Claiming a role, credential, or specific contribution (a statistical analysis never performed, data collection that didn’t happen) in order to be listed as an author, where that claim is knowingly false, functions as fabrication of the record supporting the authorship claim — not merely an aggressive negotiating position in a dispute.
Retaliation connected to raising an authorship concern
Where someone raises a good-faith concern about authorship — for example, flagging that a contribution was misattributed or that they were omitted — and is then retaliated against, that retaliation itself can be a distinct, investigable matter under an institution’s or funder’s whistleblower-protection policy, independent of whether the underlying authorship question turns out to be substantiated. See CASRAI’s guide on research misconduct whistleblower protections and how ORI investigates retaliation for how that process works.
Credit theft that also involves deception
A supervisor removing a student’s name from a paper, or a collaborator quietly changing an agreed author list before submission, is a serious ethical breach and frequently a policy violation — but whether it rises to “research misconduct” in the FFP sense depends on whether it also involved a false record or statement (e.g., a falsified justification for the change, or a false certification that all listed authors approved the final version). Absent an independent FFP element, most institutions still treat this as a serious authorship-policy violation to be handled through grievance, ombudsperson, or academic-integrity channels — just not necessarily through the specific 42 CFR Part 93 misconduct process. Institutional policies vary on exactly where this line sits, which is why the next section matters.
Who decides, and how
The determination of whether a specific authorship complaint meets the misconduct threshold is made by the institution, not the journal and not the author group itself. In US institutions receiving PHS funding, that responsibility sits with the Research Integrity Officer (RIO), the official responsible under 42 CFR 93.233 for administering the institution’s misconduct policy. The RIO’s role includes an initial assessment of whether an allegation, if true, would meet the definition of research misconduct — this is exactly the screening step that separates “send this back to the authors to resolve” from “open a formal process.”
Where an allegation does proceed, 42 CFR Part 93 defines two sequential stages, and the vocabulary matters because it signals how far the case has progressed:
- Inquiry (42 CFR 93.215): a preliminary, fact-gathering assessment of whether the allegation has enough substance to warrant a full investigation. Most authorship complaints that get any formal institutional attention at all stop here, either because they don’t meet the FFP threshold or because the inquiry itself resolves the factual dispute.
- Investigation (42 CFR 93.222): a formal, evidence-gathering process opened only once an inquiry concludes there’s a reasonable basis to believe research misconduct occurred. This is the stage that can lead to a finding, institutional sanctions, and (for PHS-funded work) a report to ORI.
By contrast, the routes described in CASRAI’s guides to resolving authorship order disputes and COPE’s ghost/guest/gift authorship flowchart — direct negotiation among authors, departmental mediation, an editor pausing peer review and requesting documentation — are deliberately kept separate from, and are typically exhausted before, any inquiry stage. Journals and editors do not make misconduct findings; COPE’s own guidance to editors is that suspected misconduct uncovered during the ghost/guest/gift authorship process should be referred to the authors’ institution, which is the same institutional-referral principle that governs unresolved order disputes.
A practical way to tell them apart
Three questions distinguish an authorship dispute from a misconduct allegation in most real cases:
- Is the disagreement about interpretation, or about a fact? “Was my contribution substantial enough to merit authorship” is an interpretive question the author group and, if needed, the institution can mediate. “Did this person actually run the analysis they’re claiming credit for” is a factual question — and if the answer involves a knowingly false record or statement, that’s the FFP element that changes the category.
- Is there an independent false record, statement, or falsified data involved? If yes, the case is not really an authorship dispute anymore; it’s a misconduct allegation that happens to be about authorship.
- Which policy governs? Under the narrow 42 CFR Part 93 definition, ghost/guest/gift authorship alone doesn’t cross the line; under UKRIO, ALLEA, or many institutions’ own broader local policies, it can. Check the actual governing policy — funder, institutional, and international frameworks genuinely disagree on where this threshold sits, so the answer is not universal.
Frequently asked questions
Is disagreeing about author order automatically research misconduct?
No. Under the US federal (42 CFR Part 93) definition, an authorship-order disagreement is a difference of opinion, which the regulation explicitly excludes from the definition of misconduct. It’s handled through direct negotiation and, if needed, institutional mediation — see CASRAI’s guide to resolving authorship order disputes.
Does ghost or guest authorship count as research misconduct?
It depends on the governing framework. It is not FFP under the narrow US federal definition, so it does not automatically trigger an ORI-jurisdiction misconduct finding. But COPE, most journals, and broader integrity frameworks such as UKRIO and ALLEA treat it as a serious integrity violation, and some institutional policies define misconduct broadly enough to include it directly.
Who decides whether an authorship complaint gets a formal misconduct inquiry?
The institution, not the journal. In US institutions receiving PHS funding, the Research Integrity Officer makes the initial assessment of whether an allegation, if substantiated, would meet the misconduct definition, and decides whether to open a formal inquiry.
What’s the difference between an inquiry and an investigation?
An inquiry (42 CFR 93.215) is the preliminary step to determine whether an allegation has enough substance to proceed further. An investigation (42 CFR 93.222) is the formal, full evidentiary process opened only once an inquiry finds a reasonable basis to believe misconduct occurred.
Can removing someone’s name from a paper be research misconduct?
On its own, not necessarily under the narrow FFP definition — but it is a serious authorship-policy violation, and it becomes an FFP matter if it involves a falsified record or a false certification about author agreement. Most institutions address unauthorized removal through grievance or academic-integrity channels even when it falls short of the federal misconduct definition.
Related CASRAI resources
- CRediT & Authorship Attribution — the full topic cluster hub.
- Resolving Authorship Order Disputes — the process for negotiating and mediating order disagreements before they reach any formal process.
- COPE’s Flowchart for Suspected Ghost, Guest, or Gift Authorship — the editorial process journals use for pre-publication suspicion.
- Research Misconduct Whistleblower Protections — what happens when raising an authorship concern triggers retaliation.
- Research misconduct (Dictionary)
- Fabrication (Dictionary)
- Falsification (Dictionary)
- Ghost authorship (Dictionary)
- Gift authorship (Dictionary)
- Research Integrity Officer (RIO) (Dictionary)
- Questionable research practices (Dictionary)
